Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04610684
Title Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Indications

lung small cell carcinoma

Therapies

Atezolizumab

Atezolizumab + Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
University of Illinois Cancer Center Recruiting Chicago Illinois 60612 United States Details
St. Vincent Anderson Regional Hospital Recruiting Anderson Indiana 46016 United States Details
Nebraska Methodist Hospital Recruiting Omaha Nebraska 68114 United States Details
Summit Health Recruiting Berkeley Heights New Jersey 07922 United States Details
Duke Cancer Institute Recruiting Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field